Endocrine and fertility effects in male cancer survivors. Changes related to androgen-deprivation therapy and other treatments require timely intervention.
Thaler-Demers
Debra
D
Stanford University Hospital and Clinics, Peterson Cancer Treatment Center, San Jose, CA, USA. debraocn@aol.com
D000970:Antineoplastic Agents / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D004249:DNA Damage; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced*; D008297:Male; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000451:nursing / Q000532:radiotherapy; D011832:Radiation Injuries; D011878:Radiotherapy / Q000009:adverse effects; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced*
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal